Showing 1,321 - 1,340 results of 128,525 for search '(( i e decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.20s Refine Results
  1. 1321
  2. 1322
  3. 1323

    POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α. by Murilo F. Roggia (755997)

    Published 2015
    “…<p><b>(A)</b> POS treatment upregulated mRNA levels of anti-oxidant enzymes including GPx1, GPx4, SOD1 and catalase. Mean ± SEM, n = 6 per group, two-tailed Student’s <i>t</i>-test, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001; ns, not significant. …”
  4. 1324
  5. 1325

    IGFBP-3 decreases vascular tone by activating scavenger receptor-B1. by Yagna P. R. Jarajapu (316562)

    Published 2013
    “…A significant decrease in myogenic tone was observed at 100 (*P<0.02, n = 5) and 300 ng/ml (**P<0.01, n = 5) IGFBP-3. …”
  6. 1326
  7. 1327
  8. 1328
  9. 1329

    Table 1_Decreased neuronal excitability in hypertriglyceridemia hamsters with acute seizures.docx by Qiuyue Shen (20373266)

    Published 2024
    “…</p>Conclusion<p>Hypertriglyceridemic Apoc2<sup>−/−</sup> hamsters exhibited reduced seizure frequency and decreased cortical neuron excitability. The upregulation of ZDHHC14, leading to increased I<sub>A</sub>, may be a crucial mechanism underlying the observed seizure protection.…”
  10. 1330

    Quantitative assays of decreased LncRNAs in I/R-treated mouse plasma. by Zhenzhen Chen (490585)

    Published 2015
    “…<p>A-E) Five downregulated LncRNAs with most meaningful decrease in expression fold picked up by microarray assays were further analyzed and confirmed by quantitative RT-PCR assay. …”
  11. 1331
  12. 1332

    Cortical distribution of neurons born at E11.5, E13.5, E15.5, or E17.5 in P0 mice. by Qingfa Chen (739620)

    Published 2015
    “…In <i>Nestin;Epha4</i><sup><i>fx/fx</i></sup> mice, a larger number of CTIP2+ cells was co-labeled with BrdU at E11.5 but fewer were co-labeled at E13.5 compared to controls (C), whereas in <i>GFAP;Epha4</i><sup><i>fx/fx</i></sup> mice, the number of co-labeled cells was similar to that of controls at both E11.5 and E13.5 (D). …”
  13. 1333

    Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-6 by John H Boyd (88940)

    Published 2011
    “…Whole fibrinogen and subunit D resulted in significant decreases in fractional shortening (FS), whereas subunit E had no significant effect. *,< 0.05 versus control.…”
  14. 1334
  15. 1335
  16. 1336

    Cardiac Development in Zebrafish and Human Embryonic Stem Cells Is Inhibited by Exposure to Tobacco Cigarettes and E-Cigarettes by Nathan J. Palpant (127912)

    Published 2015
    “…</p><p>Conclusion</p><p>These data indicate a negative effect of both tobacco cigarettes and e-cigarettes on heart development <i>in vitro</i> and <i>in vivo</i>. …”
  17. 1337
  18. 1338

    Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-0 by John H Boyd (88940)

    Published 2011
    “…Acquired with group mean data, the curves demonstrate an LPS-induced increased end diastolic volume (EDV), maintenance of stroke volume (SV), and therefore a marked reduction of left ventricular ejection fraction (SV/EDV). E, end-systolic elastance.<p><b>Copyright information:</b></p><p>Taken from "Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism"</p><p>http://ccforum.com/content/12/1/R2</p><p>Critical Care 2008;12(1):R2-R2.…”
  19. 1339

    Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-8 by John H Boyd (88940)

    Published 2011
    “…Acquired with group mean data, the curves demonstrate an LPS-induced increased end diastolic volume (EDV), maintenance of stroke volume (SV), and therefore a marked reduction of left ventricular ejection fraction (SV/EDV). E, end-systolic elastance.<p><b>Copyright information:</b></p><p>Taken from "Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism"</p><p>http://ccforum.com/content/12/1/R2</p><p>Critical Care 2008;12(1):R2-R2.…”
  20. 1340

    Chronic Arachidonic Acid Administration Decreases Docosahexaenoic Acid- and Eicosapentaenoic Acid-Derived Metabolites in Kidneys of Aged Rats by Masanori Katakura (816112)

    Published 2015
    “…Levels of docosahexaenoic acid-derived protectin D1, eicosapentaenoic acid-derived 5-, and 18-hydroxyeicosapentaenoic acids, and resolvin E2 and E3 decreased in the ARA-administered group. …”